
Angiotensin-Converting Enzyme Inhibitors, Kidney Function Tests, Risk Assessment, Phosphates, Diabetes Complications, Fumarates, Predictive Value of Tests, Humans, Renal Insufficiency, Chronic, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Prognosis, Amides, Fibroblast Growth Factors, Renal Replacement Therapy, Fibroblast Growth Factor-23, Treatment Outcome, Disease Progression, Kidney Failure, Chronic, Hypertrophy, Left Ventricular, Angiotensin II Type 1 Receptor Blockers, Biomarkers
Angiotensin-Converting Enzyme Inhibitors, Kidney Function Tests, Risk Assessment, Phosphates, Diabetes Complications, Fumarates, Predictive Value of Tests, Humans, Renal Insufficiency, Chronic, Randomized Controlled Trials as Topic, Evidence-Based Medicine, Prognosis, Amides, Fibroblast Growth Factors, Renal Replacement Therapy, Fibroblast Growth Factor-23, Treatment Outcome, Disease Progression, Kidney Failure, Chronic, Hypertrophy, Left Ventricular, Angiotensin II Type 1 Receptor Blockers, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
